by NDPH | Aug 1, 2022 | Research
Regarding clinical presentation, long COVID headache can manifest with a clinical picture similar to that of the new daily persistent headache, classified as NDPH in the ICHD-3, because of its prominent temporal relationship and resistance to treatment.
by NDPH | Jul 21, 2022 | Research
Objective: To compare the clinical phenotype of patients with chronic migraine (CM) to patients with new daily persistent headache of the chronic migraine subtype (NDPH-CM).
by NDPH | Jul 5, 2022 | Research
As headache neurologists, it is a common experience to meet a new patient with a headache that began on a particular day several months or years ago, and which has, unfortunately, been present ever since.
by NDPH | May 12, 2022 | Research
The therapeutic potential of psychedelics in headache and chronic pain disorders is documented over decades of anecdotal and early investigational reports
by NDPH | May 11, 2022 | Research
To review data regarding the epidemiology, pathophysiology, characteristics, and management of COVID-19–associated headache. The persistence of headache after the acute phase of COVID-19 was also reviewed.
by NDPH | May 1, 2022 | Research
Many people with NDPH have a self-limiting disorder that resolves in less than 1 year. Many others, however—especially those seeking neurologic care—have NDPH that is resistant to therapy and persists much longer.